NVS
NovartisยทNYSE
--
--(--)
--
--(--)
NVS Profile
Novartis Ag
A Swiss leading global medicines company that develops branded and generic pharmaceuticals, consmer health products, vaccines and diagnostics
Pharmaceutical
02/29/1996
05/12/2000
New York Stock Exchange
75,267
12-31
Depository Receipts (Ordinary Shares)
Lichtstrasse 35, 4056 Basel, Switzerland
Research, develop, manufacture and sell patented medicines in the fields of cancer and blood diseases
Novartis AG was incorporated on February 29, 1996 as a joint stock company under the laws of Switzerland. The company is an innovative pharmaceutical company engaged in research, development, manufacturing, distribution, marketing and sales of a wide range of pharmaceutical products. It focuses on core therapeutic areas including cardiovascular, renal and metabolic diseases, immunology, neuroscience and oncology.
